Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Callens C, Driouch K, Boulai A, Tariq Z, Comte A, Berger F, Belin L, Bièche I, Servois V, Legoix P, Bernard V, Baulande S, Chemlali W, Bidard FC, Fourchotte V, Salomon AV, Brain E, Lidereau R, Bachelot T, Saghatchian M, Campone M, Giacchetti S, Zafrani BS, Cottu P. Callens C, et al. Among authors: fourchotte v. Genome Med. 2021 Mar 15;13(1):44. doi: 10.1186/s13073-021-00862-6. Genome Med. 2021. PMID: 33722295 Free PMC article.
A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
Meyniel JP, Cottu PH, Decraene C, Stern MH, Couturier J, Lebigot I, Nicolas A, Weber N, Fourchotte V, Alran S, Rapinat A, Gentien D, Roman-Roman S, Mignot L, Sastre-Garau X. Meyniel JP, et al. Among authors: fourchotte v. BMC Cancer. 2010 May 21;10:222. doi: 10.1186/1471-2407-10-222. BMC Cancer. 2010. PMID: 20492709 Free PMC article.
Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution Study.
de la Rochefordiere A, Kirova Y, Alran S, Plancher C, Fourchotte V, Beuzeboc P, de Margerie V, Petrow P, Sastre-Garau X, Servois V, Scholl S, Cottu P, Mignot L, de Cremoux P, Salmon R. de la Rochefordiere A, et al. Among authors: fourchotte v. Clin Med Oncol. 2008;2:227-36. doi: 10.4137/cmo.s489. Epub 2008 Mar 27. Clin Med Oncol. 2008. PMID: 21892284 Free PMC article.
Outcome in Advanced Ovarian Cancer following an Appropriate and Comprehensive Effort at Upfront Cytoreduction: A Twenty-Year Experience in a Single Cancer Institute.
Marszalek A, Alran S, Scholl S, Fourchotte V, Plancher C, Rosty C, Meyniel JP, De Margerie V, Dorval T, De La Rochefordière A, Cottu P, Petrow P, Sastre-Garrau X, Salmon RJ. Marszalek A, et al. Among authors: fourchotte v. Int J Surg Oncol. 2010;2010:214919. doi: 10.1155/2010/214919. Epub 2010 Jul 25. Int J Surg Oncol. 2010. PMID: 22312486 Free PMC article.
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.
Campitelli M, Jeannot E, Peter M, Lappartient E, Saada S, de la Rochefordière A, Fourchotte V, Alran S, Petrow P, Cottu P, Pierga JY, Lantz O, Couturier J, Sastre-Garau X. Campitelli M, et al. Among authors: fourchotte v. PLoS One. 2012;7(8):e43393. doi: 10.1371/journal.pone.0043393. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22937045 Free PMC article.
Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.
Reyal F, Belichard C, Rouzier R, de Gournay E, Senechal C, Bidard FC, Pierga JY, Cottu P, Lerebours F, Kirova Y, Feron JG, Fourchotte V, Vincent-Salomon A, Guinebretiere JM, Sigal-Zafrani B, Sastre-Garau X, De Rycke Y, Coutant C. Reyal F, et al. Among authors: fourchotte v. PLoS One. 2012;7(10):e47390. doi: 10.1371/journal.pone.0047390. Epub 2012 Oct 9. PLoS One. 2012. PMID: 23056641 Free PMC article.
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.
Reyal F, Hajage D, Savignoni A, Feron JG, Bollet MA, Kirova Y, Fourquet A, Pierga JY, Cottu P, Dieras V, Fourchotte V, Laki F, Alran S, Asselain B, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X. Reyal F, et al. Among authors: fourchotte v. PLoS One. 2013;8(3):e55901. doi: 10.1371/journal.pone.0055901. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23526930 Free PMC article.
PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients.
de la Rochefordiere A, Kamal M, Floquet A, Thomas L, Petrow P, Petit T, Pop M, Fabbro M, Kerr C, Joly F, Sevin E, Maillard S, Curé H, Weber B, Brunaud C, Minsat M, Gonzague L, Berton-Rigaud D, Aumont M, Gladieff L, Peignaux K, Bernard V, Leroy Q, Bieche I, Margogne A, Nadan A, Fourchotte V, Diallo A, Asselain B, Plancher C, Armanet S, Beuzeboc P, Scholl SM. de la Rochefordiere A, et al. Among authors: fourchotte v. Clin Cancer Res. 2015 Jun 1;21(11):2530-7. doi: 10.1158/1078-0432.CCR-14-2368. Epub 2015 Feb 27. Clin Cancer Res. 2015. PMID: 25724520 Clinical Trial.
79 results